Identifying and Validating a Combined mRNA and MicroRNA Signature in Response to Imatinib Treatment in a Chronic Myeloid Leukemia Cell Line

Open Access

Peer-reviewed

Research Article

Steven Bhutra,

Affiliation Pritzker School of Medicine, University of Chicago, Chicago, Illinois, United States of America
⨯
Divya Lenkala,

Affiliation Department of Medicine, University of Chicago, Chicago, Illinois, United States of America
⨯
Bonnie LaCroix,

Affiliation Department of Medicine, University of Chicago, Chicago, Illinois, United States of America
⨯
Meng Ye,

Affiliation The Affiliated Hospital, School of Medicine, Ningbo University, Ningbo, Zhejiang, China
⨯
R. Stephanie Huang

* E-mail: rhuang@medicine.bsd.uchicago.edu

Affiliations Department of Medicine, University of Chicago, Chicago, Illinois, United States of America, The Affiliated Hospital, School of Medicine, Ningbo University, Ningbo, Zhejiang, China
⨯

Reader Comments (0)

MicroRNAs
Is the Subject Area "MicroRNAs" applicable to this article?

Thanks for your feedback.
Transfection
Is the Subject Area "Transfection" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
Patients
Is the Subject Area "Patients" applicable to this article?

Thanks for your feedback.
Biomarkers
Is the Subject Area "Biomarkers" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.